What are the recommended doses of methylergometrine (Methergine) and carboprost tromethamine (Hemabate) for managing postpartum hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosing for Methergine and Carboprost in Postpartum Hemorrhage

For methergine (methylergonovine): give 0.2 mg intramuscularly, and for carboprost (Hemabate): give 250 mcg intramuscularly as the initial dose.

Methergine (Methylergonovine) Dosing

Initial dose: 0.2 mg intramuscularly 1

  • Can be given 3-4 times daily for up to 1 week postpartum if needed for ongoing bleeding control
  • May also be administered intravenously (slow IV) or orally depending on clinical scenario
  • Avoid in patients with hypertension, preeclampsia, or vascular disease due to vasoconstrictive effects 2

Key Contraindications

  • Do not use with potent CYP 3A4 inhibitors (macrolide antibiotics like erythromycin, HIV protease inhibitors, azole antifungals) due to risk of severe vasospasm and ischemia 1
  • Contraindicated during pregnancy (only for postpartum use)

Carboprost (Hemabate) Dosing

Initial dose: 250 mcg (1 mL) deep intramuscular injection 3

  • Repeat doses of 250 mcg can be given at intervals of 15-90 minutes as clinically indicated
  • May increase to 500 mcg (2 mL) if uterine contractility inadequate after several 250 mcg doses
  • Maximum total dose: 2 mg (8 doses) for postpartum hemorrhage 3
  • In clinical trials, 73% of successful cases responded to a single injection 3

Important Caveat

Carboprost can cause bronchoconstriction—avoid in patients with asthma 2. This is a critical safety consideration that distinguishes it from other uterotonics.

Clinical Context and Comparative Efficacy

The evidence shows these agents work effectively as second-line uterotonics when oxytocin fails:

  • A 2024 randomized trial found no significant difference between methylergonovine and carboprost for refractory uterine atony, with mean uterine tone scores of 7.3±1.7 vs 7.6±2.1 at 10 minutes (p=0.76) 4
  • Both required additional uterotonics in approximately 30-34% of cases 4
  • Either agent is acceptable as second-line therapy—choice should be based on patient-specific contraindications (hypertension/vascular disease for methergine; asthma for carboprost)

Practical Algorithm

  1. First-line: Oxytocin 10 IU IV/IM immediately after delivery
  2. If atony persists: Choose based on contraindications:
    • No asthma: Carboprost 250 mcg IM (can repeat q15-90min, max 2mg)
    • No hypertension/vascular disease: Methergine 0.2 mg IM
    • Both contraindicated: Consider misoprostol or tranexamic acid

The dosing intervals for carboprost are more flexible (15-90 minutes) compared to the fixed dosing schedule sometimes used for methergine, allowing for more responsive titration to clinical effect 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.